FRESENIUS MEDICAL CARE AG (FME.DE) Stock Earnings Estimates
FRA:FME • DE0005785802
39.45 EUR
+0.23 (+0.59%)
Last: Feb 27, 2026, 07:00 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 19.398B 10.10% | 19.454B 0.29% | 19.336B -0.61% | 19.751B 2.15% | 20.176B 2.15% | 21.009B 4.13% | 22.679B 7.95% | 22.704B 0.11% | 23.785B 4.76% | 24.256B 1.98% | 25.192B 3.86% | 26.145B 3.78% | |
| EBITDA YoY % growth | 3.125B -8.15% | 3.03B -3.03% | 3.008B -0.73% | 3.578B 18.94% | 3.683B 2.93% | 3.905B 6.03% | 4.1B 4.99% | 4.187B 2.12% | 4.68B 11.77% | 4.871B 4.08% | 5.046B 3.59% | 5.225B 3.55% | |
| EBIT YoY % growth | 1.287B -27.66% | 1.278B -0.65% | 1.266B -0.97% | 2.092B 65.26% | 2.16B 3.25% | 2.389B 10.60% | 2.822B 18.12% | 2.988B 5.88% | 3.286B 9.97% | 3.472B 5.66% | 3.609B 3.95% | 3.75B 3.91% | |
| Operating Margin | 6.63% | 6.57% | 6.55% | 10.59% | 10.71% | 11.37% | 12.44% | 13.16% | 13.82% | 14.31% | 14.33% | 14.34% | |
| EPS YoY % growth | 3.10 -10.14% | 2.57 -17.23% | 3.25 26.66% | 3.96 9.36% | 4.15 16.67% | 4.71 13.57% | 5.59 18.65% | 5.78 3.42% | 6.38 10.32% | 6.64 4.09% | 7.13 7.49% | 7.57 6.15% |
All data in EUR
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | 0.79 -6.00% | 0.79 -13.43% | 0.88 -19.66% | 0.76 7.56% |
| Revenue Q2Q % growth | 4.854B -0.55% | 4.988B 4.09% | 5.124B 4.89% | 5.299B 5.81% |
| EBITDA Q2Q % growth | 851.66M 13.30% | 932.15M -19.33% | 984.25M -37.62% | 1.042B -1.98% |
| EBIT Q2Q % growth | 474.46M 32.79% | 517.54M 34.11% | 568.13M 26.00% | 668.62M 3.53% |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | 0.70 -22.61% | 1.03 | -0.33 | -31.87% |
| Q3 2025 Q2Q % growth | 1.10 34.15% | 0.96 | 0.14 | 14.16% |
| Q2 2025 Q2Q % growth | 0.91 30.00% | 0.79 | 0.12 | 14.89% |
| Q1 2025 Q2Q % growth | 0.84 2.44% | 0.66 | 0.18 | 27.17% |
| Q4 2024 Q2Q % growth | 0.91 3.41% | 0.79 | 0.12 | 15.03% |
| Q3 2024 Q2Q % growth | 0.82 43.86% | 0.65 | 0.17 | 25.81% |
| Q2 2024 Q2Q % growth | 0.70 17.45% | 0.68 | 0.02 | 2.71% |
| Q1 2024 Q2Q % growth | 0.82 57.69% | 0.60 | 0.22 | 37.27% |
| Q4 2023 Q2Q % growth | 0.88 2.33% | 0.94 | -0.06 | -6.11% |
| Q3 2023 Q2Q % growth | 0.57 -27.85% | 0.52 | 0.05 | 9.44% |
| Q2 2023 Q2Q % growth | 0.60 -22.60% | 0.51 | 0.09 | 16.93% |
| Q1 2023 Q2Q % growth | 0.52 -23.53% | 0.52 | 0.00 | -0.29% |
| Q4 2022 Q2Q % growth | 0.86 -4.44% | 0.79 | 0.07 | 8.43% |
| Q3 2022 Q2Q % growth | 0.79 -15.96% | 0.68 | 0.11 | 15.76% |
| Q2 2022 Q2Q % growth | 0.77 1.32% | 0.83 | -0.06 | -7.29% |
| Q1 2022 Q2Q % growth | 0.68 -20.00% | 0.70 | -0.02 | -2.50% |
| Q4 2021 Q2Q % growth | 0.90 -29.13% | 0.88 | 0.02 | 2.03% |
| Q3 2021 Q2Q % growth | 0.94 -22.31% | 0.92 | 0.02 | 2.46% |
| Q2 2021 Q2Q % growth | 0.76 -36.67% | 0.76 | 0.00 | 0.20% |
| Q1 2021 Q2Q % growth | 0.85 -10.53% | 0.80 | 0.05 | 5.83% |
| Q4 2020 Q2Q % growth | 1.27 | 1.21 | 0.06 | 4.92% |
| Q3 2020 Q2Q % growth | 1.21 | 1.16 | 0.05 | 4.36% |
| Q2 2020 Q2Q % growth | 1.20 | 1.09 | 0.11 | 10.07% |
| Q1 2020 Q2Q % growth | 0.95 | 0.87 | 0.08 | 8.84% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | 5.008B -1.52% | 4.891B | 116.923M | 2.39% |
| Q3 2025 Q2Q % growth | 4.885B 2.63% | 4.97B | -85M | -1.71% |
| Q2 2025 Q2Q % growth | 4.792B 0.55% | 4.957B | -165M | -3.33% |
| Q1 2025 Q2Q % growth | 4.881B 3.31% | 4.751B | 130M | 2.74% |
| Q4 2024 Q2Q % growth | 5.085B 1.94% | 4.795B | 290M | 6.05% |
| Q3 2024 Q2Q % growth | 4.76B -3.57% | 4.979B | -219M | -4.40% |
| Q2 2024 Q2Q % growth | 4.766B -1.22% | 5.014B | -248M | -4.95% |
| Q1 2024 Q2Q % growth | 4.725B 0.43% | 4.681B | 43.522M | 0.93% |
| Q4 2023 Q2Q % growth | 4.988B -0.18% | 5.002B | -14M | -0.28% |
| Q3 2023 Q2Q % growth | 4.936B -3.14% | 4.952B | -16M | -0.32% |
| Q2 2023 Q2Q % growth | 4.825B 1.44% | 4.824B | 1M | 0.02% |
| Q1 2023 Q2Q % growth | 4.704B 3.43% | 4.767B | -62.782M | -1.32% |
| Q4 2022 Q2Q % growth | 4.997B 7.53% | 5.054B | -57.198M | -1.13% |
| Q3 2022 Q2Q % growth | 5.096B 14.74% | 5.093B | 3.166M | 0.06% |
| Q2 2022 Q2Q % growth | 4.757B 10.10% | 4.811B | -54.32M | -1.13% |
| Q1 2022 Q2Q % growth | 4.548B 8.03% | 4.516B | 32.369M | 0.72% |
| Q4 2021 Q2Q % growth | 4.647B 5.61% | 4.654B | -6.976M | -0.15% |
| Q3 2021 Q2Q % growth | 4.441B 0.63% | 4.517B | -75.634M | -1.67% |
| Q2 2021 Q2Q % growth | 4.32B -5.20% | 4.363B | -42.83M | -0.98% |
| Q1 2021 Q2Q % growth | 4.21B -6.19% | 4.272B | -61.875M | -1.45% |
| Q4 2020 Q2Q % growth | 4.4B | 4.495B | -94.846M | -2.11% |
| Q3 2020 Q2Q % growth | 4.414B | 4.439B | -25.232M | -0.57% |
| Q2 2020 Q2Q % growth | 4.557B | 4.504B | 53.345M | 1.18% |
| Q1 2020 Q2Q % growth | 4.488B | 4.466B | 21.796M | 0.49% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 12.25% | 14.55% | 0% | 2.83% |
| Revenue | 0.31% | 0.62% | 0.02% | 0.39% |